Ambulatory Screening for Specific Learning Disabilities (SLD) and Developmental Coordination Disorder (DCD).
NCT ID: NCT04122820
Last Updated: 2019-10-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
1800 participants
INTERVENTIONAL
2019-10-16
2022-10-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Orthophonic and / or Proprioceptive Treatment of Developmental Dyslexia.
NCT03448237
Developmental Language Difficulties: Behavioural and Electrophysiological Studies
NCT02872870
Developmental Dyslexia and Remediation Methods
NCT04028310
Usefulness of an Assistive Technology Training Program for Adolscents With Dyslexia
NCT05636813
Theory of Mind in Children With DCD
NCT06183411
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Each trained practitioner will then test at least six children aged 8 to 12 years old in his or her practice, seen at random
250 to 300 physicians will be trained as part of this research
EXPERIMENTAL DESIGN
* Cross-sectional study with prospective recruitment.
* Search for a Vertical Labile Heterophory (HV-Labile).
* Prescription of a standardized speech and language screening assessment for HV-Labile, and in the same number of children without HV-Labile by secondary coupling.
* Delivery of symptomatic questionnaire.
* In case of learning disabilities, the attending physician should look for a possible etiology.
* Adapted speech therapy care for more than six months.
* Speech and language therapy check-up at more than six months.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SCREENING
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Presence of HV-Labile
Presence of vertical heterophoria labile with proprioceptive Maddox
Diagnostic of specific learning disabilities or of Developmental Coordination Disorder
Speech therapy assessment, or occupational therapy. In case of pathological disorder, search for a sensory disorder, and therapeutic management. If the pathological disorder persists for more than six months, elimination of a secondary etiology.
Absence of HV-Labile
Presence of stable vertical heterophoria or stable orthophoria with proprioceptive Maddox
Diagnostic of specific learning disabilities or of Developmental Coordination Disorder
Speech therapy assessment, or occupational therapy. In case of pathological disorder, search for a sensory disorder, and therapeutic management. If the pathological disorder persists for more than six months, elimination of a secondary etiology.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Diagnostic of specific learning disabilities or of Developmental Coordination Disorder
Speech therapy assessment, or occupational therapy. In case of pathological disorder, search for a sensory disorder, and therapeutic management. If the pathological disorder persists for more than six months, elimination of a secondary etiology.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* from 8 to 12 years old
* seen for any reason for consultation in general practice
* Schooled in an ordinary environment since the Preparatory Course in France
* Francophone parents
* One of whose parents has signed the consent
* Consent of the child
* Social Insured
Exclusion Criteria
* Child with a known intellectual disability (Wisc)
* Child in IME (Institut Médico Educatif)
* Child followed in SESSAD (Specialised education service at home)
* Child not knowing how to answer the questions asked
* Child with a known etiology causing learning disabilities (epilepsy, autism spectrum disorder, hearing impairment, visual impairment (deafness, blindness, low vision))
* Child on treatment (antiepileptic, neuroleptic, antidepressant, anxiolytic)
* Child under the care of a psychiatrist,
* Child followed by the CMP (Centre médico-psychologique)
* Child living in an institution,
* Adopted child
* A child whose mother has experienced known depression during the child's early childhood (0-18 months) because it causes attachment disorders, which can impact the child's development, including learning
* Child of a family that has lived through more than two family recompositions
* Child known to be a victim of abuse.
* Out of school child.
To determine the presence of an HV-Labile
* Child with a known visual correction greater than + or- 2 diopters
* Known amblyopic child
* Known strabic child
* Child with no known binocular vision.
8 Years
12 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Scalab CNRS 9193
OTHER
CNGE IRMG Association
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Luc Virlet
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Luc Virlet
Role: PRINCIPAL_INVESTIGATOR
SCalab CNRS 9193, Lille University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Office-based general practioner
Strasbourg, Alsace, France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
References
Explore related publications, articles, or registry entries linked to this study.
Quercia P, Quercia M, Feiss LJ, Allaert F. The distinctive vertical heterophoria of dyslexics. Clin Ophthalmol. 2015 Sep 25;9:1785-97. doi: 10.2147/OPTH.S88497. eCollection 2015.
Related Links
Access external resources that provide additional context or updates about the study.
The study undertaken with 100 all-view children shows a strong correlation between the presence of SDP-HV-labile and the presence of specific learning disorders. She encourages us not to neglect the proprioceptive approach in the study of the SLD.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2019-A00416-51
Identifier Type: REGISTRY
Identifier Source: secondary_id
CNGEIRMG 0310
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.